Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive

Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04216563	ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor	terminated	Phase 2	7	M.D. Anderson Cancer CenterOTHER	1	Mar 2, 2026	clinicaltrials
NCT02228382	Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors	terminated	Phase 4	163	PfizerINDUSTRY	8	Dec 30, 2021	clinicaltrials